Home › Depression › Connecticut
Depression clinical trials in Connecticut
15 studies for Depression are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Oct 5, 2026 · NCT06793397A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT07412756The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
- Yale University, New Haven
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 28, 2026 · NCT07610369A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Mood Institute, Milford
- Yale School of Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06713616A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 8, 2026 · NCT07076407E-Mindfulness Approaches for Living After Breast Cancer
- Stamford Hospital/Bennett Cancer Center, Stamford
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06966401Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
- Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 21 to 65 · All sexes · Updated Jun 16, 2026 · NCT06671977Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
- Yale University, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated May 29, 2026 · NCT05810259The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated May 6, 2026 · NCT05786066Stress and Pain in People Living With HIV
- The Yale Stress Center, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 68 · All sexes · Updated Apr 27, 2026 · NCT06784908External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
RecruitingObservational study
Ages 18 to 44 · Women · Updated Apr 15, 2026 · NCT06788977Open-Label Psilocybin Study in Transdiagnostic Population
- Connecticut Mental Health Center - Yale School of Medicine, New Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06442423From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.